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Abstract
Background: Although guidelines recommend palliative care for patients with chronic obstructive pulmonary disease, there is little 
evidence for the effectiveness of palliative care interventions for this patient group specifically.
Aim: To describe the characteristics of palliative care interventions for patients with COPD and their informal caregivers and review 
the available evidence on effectiveness and implementation outcomes.
Design: Systematic review and narrative synthesis (PROSPERO CRD42017079962).
Data sources: Seven databases were searched for articles reporting on multi-component palliative care interventions for study 
populations containing ⩾30% patients with COPD. Quantitative as well as qualitative and mixed-method studies were included. 
Intervention characteristics, effect outcomes, implementation outcomes and barriers and facilitators for successful implementation 
were extracted and synthesized qualitatively.
Results: Thirty-one articles reporting on twenty unique interventions were included. Only four interventions (20%) were evaluated in 
an adequately powered controlled trial. Most interventions comprised of longitudinal palliative care, including care coordination and 
comprehensive needs assessments. Results on effectiveness were mixed and inconclusive. The feasibility level varied and was context-
dependent. Acceptability of the interventions was high; having someone to call for support and education about breathlessness were 
most valued characteristics. Most frequently named barriers were uncertainty about the timing of referral due to the unpredictable 
disease trajectory (referrers), time availability (providers) and accessibility (patients).
Conclusion: Little high-quality evidence is yet available on the effectiveness and implementation of palliative care interventions for 
patients with COPD. There is a need for well-conducted effectiveness studies and adequate process evaluations using standardized 
methodologies to create higher-level evidence and inform successful implementation.
Keywords
Chronic obstructive pulmonary disease, palliative care, breathlessness, quality of life, systematic review
1 Public Health & Primary care, Leiden University Medical Centre, 
Leiden, The Netherlands
2Lung Alliance Netherlands, The Netherlands
3 Centre of Expertise for Palliative Care, University of Groningen and 
University Medical Centre Groningen, Groningen, The Netherlands
4Department of Research & Development, CIRO, Horn, The Netherlands
5 Department of Health Services Research, Care and Public Health 
Research Institute, Faculty of Health, Medicine and Life Sciences, 
Maastricht University, The Netherlands
6 department of Respiratory Medicine & Tuberculosis, and Groningen 
Research Institute for Asthma and COPD (GRIAC), University of 
Groningen and University Medical Centre Groningen, Groningen, The 
Netherlands
7 Anaesthesiology, Pain & Palliative Medicine, Radboud University 
Medical Centre, Nijmegen, The Netherlands
Corresponding author:
Johanna MC Broese, Department of Public Health and Primary Care, 
Leiden University Medical Centre, Post zone V0-P, Postbus 9600, Leiden 
2300 RC, The Netherlands. 
Email: j.m.c.broese@lumc.nl
981294 PMJ0010.1177/0269216320981294Palliative MedicineBroese et al.
review-article2020
Review Article
Broese et al. 487
What is already known about the topic?
•• Patients with advanced COPD have a high symptom burden and impaired quality of life. Although guidelines rec-
ommend palliative care for patients with COPD, implementation remains often challenging and an up-to-date 
overview of the evidence on its effectiveness is lacking.
What this paper adds?
•• This review provides a comprehensive overview of evidence on the effectiveness and implementation of pallia-
tive care interventions targeting patients with COPD and their informal caregivers.
•• Within different care contexts, short-term palliative care assessments as well as longitudinal palliative care inter-
ventions with care coordination have been implemented. Highly valued intervention characteristics are the direct 
access to a professional for support, an ongoing relationship with a professional and education about 
breathlessness.
•• Few interventions have been evaluated using a controlled study design. Positive effects were found on outcomes 
related to advance care planning and perceived symptom control and self-management, but not on health 
outcomes.
Implications for practice, theory or policy
•• Research on palliative care in COPD should focus on what is important to patients with end-stage COPD and their 
informal caregivers. More knowledge is needed on which outcomes best reflect their needs.
•• Controlled studies with sufficient power are needed to evaluate the effectiveness of palliative care on patients 
with COPD and their informal caregivers.
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is the 
third leading cause of death worldwide.1 Patients suffer-
ing from end-stage COPD experience severe breathless-
ness and other debilitating symptoms such as fatigue, 
pain, anxiety and depression, leading to poor quality of 
life and emphasizing the need for adequate palliative 
care.2 Palliative care aims to improve the quality of life of 
patients with a life-threatening disease and their families 
by early identification, assessment and treatment of phys-
ical, psychological, social and spiritual problems.3 Growing 
evidence suggests that palliative care, in general, has posi-
tive effects on quality of life and can decrease symptom 
burden in patients with life-limiting illnesses. Additionally, 
it can improve patient and informal caregiver satisfaction 
with care and reduces healthcare utilization.4 However, 
for patients with advanced COPD, palliative care is not yet 
part of standard care, and discussions about goals of (end-
of-life) care rarely take place, or only late in the disease 
course.5 As a consequence, their severe symptoms remain 
undertreated, and a large proportion of this patient group 
inadvertently dies in the hospital.6,7 Moreover, the long 
disease course with declining functional capacity affects 
their informal caregivers.8
Implementing palliative care for patients with COPD is 
challenging. Due to the unpredictable disease trajectory, 
healthcare professionals struggle to determine when to 
refer patients for specialized palliative care.9 Further, palli-
ative care for patients with COPD needs to be differently 
organized than for oncological patients because it demands 
integration of palliative care and disease-oriented care 
until the end-of-life.10 The implementation of palliative 
care in COPD-care is further complicated as professionals 
must perform actions they are not used to, such as discuss-
ing holistic needs and end-of-life topics.9
Although guidelines recommend palliative care for 
patients with COPD, there is little evidence for the 
effectiveness of palliative care interventions for this 
patient group specifically.11,12 In previous systematic 
reviews, the vast majority of the interventions 
described were designed for patients with cancer4,13,14 
or focused on a single intervention component only.15–
17 Research on the effectiveness of interventions that 
integrate multiple components of palliative care for 
patients with COPD is still lacking.18 Further, it remains 
unclear how palliative care can be organized for this 
patient group and what are requirements for successful 
implementation. Finally, no reviews have included 
intervention outcomes at the level of the informal car-
egiver and professional.
To guide future palliative care provision for patients 
with COPD and to identify gaps in the current evidence-
base, we, therefore, aimed to review multi-component 
palliative care interventions targeting patients with 
advanced COPD and their informal caregivers. Specifically, 
we aimed to:
1. Synthesize the characteristics of multi-component 
palliative care interventions targeting patients 
with COPD and their informal caregivers;
2. Review the evidence for the effectiveness of those 
interventions on patient, informal caregiver and 
healthcare professional outcomes;
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3. Review the evidence on implementation outcomes 
and barriers and facilitators of implementation.
Methods
The protocol of this systematic review has been registered 
in the international Prospective Register of Systematic 
Reviews (PROSPERO) database (ID: CRD42017079962). 
We used the Cochrane Handbook for Systematic Reviews 
of Interventions to perform the review, and followed the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) statement for reporting.
Literature search
The electronic databases MEDLINE, Embase, Web of 
Science, COCHRANE Library, PsycINFO, CENTRAL and 
Emcare were searched for eligible studies. In the search 
strategy, we combined a broad range of synonyms of the 
search terms “COPD” and “palliative care” (Supplemental 
Table 1). Articles that were published between 1 January 
1990 and 9 June 2020 were screened for inclusion, with-
out language restrictions. We searched for other poten-
tially relevant studies by screening the reference lists and 
citations of included studies.
Study selection
Articles reporting on primary research data of multi-com-
ponent palliative care interventions targeting patients with 
COPD were included. The intervention described in the 
article needed to be referred to as a palliative care or end-
of-life care intervention, program or approach. We defined 
a multi-component intervention as an intervention com-
prising multiple components which interact to produce 
change, following the complex intervention definition of 
the Medical Research Council.19 Interventions focusing 
only on a single component (such as advance care plan-
ning or opioids for breathlessness) were excluded. If the 
study population was mixed, articles were included if at 
least 30% of the study population suffered from COPD. 
Case reports and non-primary research data, such as 
reviews, editorials, conference abstracts and books were 
excluded. We also included uncontrolled before-and-after 
studies, qualitative and mixed-method studies, as this (1) 
reflects the most frequent type of studies performed and 
provides a comprehensive overview of all available evi-
dence, and (2) because we wanted to gain in-depth insight 
into mechanisms or elements contributing most to inter-
vention effectiveness and successful implementation. Title 
and abstract screening and subsequent full-text screening 
was done by two reviewers independently (J.B., and J.S. or 
A.H.). In case of any incongruences, the in- or exclusion of 
an article was discussed until consensus was reached. In 
case of doubt, a third researcher (R.K.) was consulted.
Data extraction
Data on design, participants, intervention characteris-
tics and all reported outcomes at patient, informal car-
egiver and healthcare professional level were extracted 
using a piloted extraction form. If necessary and possi-
ble, additional data was derived from published study 
protocols or supplementary documents, or requested 
from the authors. Data extraction of the included arti-
cles was done by two reviewers independently (J.B. as 
first reviewer for all articles and A.H., D.J., Y.E., or R.K. as 
a second reviewer). Any incongruencies were discussed 
until consensus was reached. Implementation outcomes 
and barriers and facilitators for implementation were 
extracted by one reviewer (J.B.) and discussed with a 
second reviewer who has great expertise in implemen-
tation (R.K.).
Quality appraisal
Quality appraisal was performed by two reviewers (J.B. 
and A.H.) independently, using the Mixed Methods 
Appraisal Tool.20 After two screening questions, each 
study is appraised by rating appraisal criteria for the cor-
responding category. Any discrepancies in the quality 
appraisal were resolved by discussion, and if needed, a 
third reviewer (R.K.) was consulted. To compare study 
quality, we assigned four stars to a study when 75 to 100% 
of the criteria were positively rated (high quality), three 
stars for 50–75% (moderate quality), two stars for 25–50% 
(low quality) and one star for 0–25% (very low quality).
Data analysis
Data were analysed using narrative synthesis.21 Study 
characteristics were summarized in terms of country, 
design, objective, study participants, inclusion strategy, 
intervention and organizational characteristics and out-
comes. The intervention components were categorized 
according to twelve palliative care domains based on 
the Dutch Quality Framework Palliative care,12 Clinical 
Practice Guidelines for Quality Palliative Care22 and 
Quality standard End of life care for adults.23 The opera-
tionalization of domains is described in Supplemental 
Table 2. Outcomes were classified into three categories: 
outcomes at patient, informal caregiver, and healthcare 
professional level. Quantitative results reported in stud-
ies in which no statistical testing was performed, were 
disregarded. The text in articles reporting on qualitative 
outcomes was coded phrase by phrase after which com-
mon themes were identified.24 We categorized 
implementation outcomes following the proposed ter-
minology and operationalization of Proctor et al.25 (see 
Supplemental Table 3). According to Proctor et al.,25 
implementation outcomes are defined as “the effects of 
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deliberate and purposive actions to implement new 
treatments, practices, and services” (page 65). Process 
outcomes reflecting trial feasibility (and not interven-
tion feasibility) were not evaluated. Barriers and facilita-
tors to implementation of palliative care interventions 
were categorized using the framework of Fleuren et al.26 
This instrument consists of 29 determinants in four cat-
egories: determinants associated with the (a) innova-
tion, (b) adopting person, (c) organization, and (d) 
socio-political context. We extracted determinants for 
three types of users: referrers (professionals who refer 
patients to the palliative care intervention), providers 
(professionals who provide the intervention) and 
patients (individuals who receive the intervention). If 
needed, determinants of the Consolidated Framework 
for Implementation Research27 or newly defined deter-
minants were added inductively. The codebook used is 
available in Supplemental Table 4.
Results
The database search yielded 5621 unique records. In total, 
166 articles were excluded based on publication date. 
Next, we excluded 5310 articles based on title-abstract 
screening. The full-text versions of the remaining 145 arti-
cles were assessed for eligibility. Twenty-three of them 
met inclusion criteria. Screening of references and cita-
tions of included articles identified eight additional arti-
cles. A flow diagram of the study selection is displayed in 
Figure 1. Finally, 31 articles were included that reported 
on 20 unique palliative care interventions; six interven-
tions were evaluated in more than one article.
Study characteristics
Characteristics of included studies and interventions are 
summarized in Table 1. All studies took place in western 
countries, of which most in the USA (n = 5) and the United 
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Figure 1. PRISMA flow diagram of the study selection process.
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































494 Palliative Medicine 35(3)
Kingdom (n = 4). Three RCTs,28–30 two non-randomized 
controlled trials,31–33 seven uncontrolled before-and-after 
studies,34–41 six qualitative studies,42–47 one non-compara-
tive study,48 and 10 pilot/feasibility studies37,49–57 were 
included. The study design of one article was unclear.58 
Two articles reported on the same study and were col-
lated.32,33 Five quantitative studies30,33,35,41,48 and six pilot/
feasibility studies37,50–52,54,55 also included qualitative data. 
Eighteen studies (60%) focused specifically on COPD. Other 
studies focussed on refractory breathlessness29,30,38,42,43,54 
or also included patients with heart failure28,34,44,58 or heart 
failure and cancer.33,45 Sample sizes in quantitative studies 
ranged from 13 to 228 patients and in qualitative (sub)
studies from 6 to 78 patients. The mean age of study popu-
lations ranged between 63 and 76 years.
Intervention characteristics
Half of the interventions were developed based on lit-
erature according to the description in the article; two 
were based on specific guidelines. Thirteen of the 
twenty interventions comprised of longitudinal care in 
which there was regular contact of a nurse with patients 
via home visits,28,34–36,39,44,55,57 outpatient visits31,33,47 or 
a combination of both.38 Vitacca et al.56 included telem-
onitoring. The majority of longitudinal care interven-
tions included symptom management and needs 
assessments, disease education and self-management, 
advance care planning and care coordination (Table 2). 
Informal caregiver support was incorporated in eight 
interventions and consisted of caregiver educa-
tion,28,30,33,35,38 nurse assessment of needs,28,33,44,55,57 
invitation to support groups33 and respite care38 and 
was unspecified in Iupati and Ensor.36 Most were organ-
ized by a community care organization, such as a hos-
pice care service or home service. Six other interventions 
comprised of one comprehensive needs assessment 
with a short follow up.29,30,37,52–54 They included one to 
four home visits and/or outpatient visits and were 
mostly organized by pulmonary care and palliative care 
departments. Four interventions specifically focussed 
on the management of breathlessness29,30,37,54 and com-
prised of various pharmacological and non-pharmaco-
logical interventions to address breathlessness and how 
to cope with this symptom. Farquhar et al. also included 
informal caregiver education. Lastly, one intervention 
was a 6-week multidisciplinary geriatric rehabilitation 
program in a specialist nursing facility. Patients in need 
of palliative care were proactively identified by six inter-
ventions, by screening patients during hospitalization 
for acute exacerbation31,40,52 or by using a computerized 
screening program based on diagnosis and hospitaliza-
tions or measures of disease severity.33,34 In most other 
cases, patients were referred to the service by health-
care professionals.
Quality appraisal
Ratings of the criteria of the Mixed Methods Appraisal 
Tool per study are provided in Supplementary Table 5. 
Quality of the studies was related to the study design 
used. All three RCTs were of high quality; non-randomized 
controlled trials and qualitative studies were of moderate 
to high quality; study quality of uncontrolled studies 
ranged from very low to moderate. The quality of pilot/
feasibility studies varied from low to high. Two articles 
were not appraised as they did not pass the screening 
questions.35,58 The following reasons most frequently con-
tributed to a negative rating: lack of information on inter-
vention adherence in controlled trials, insufficient use of 
quotations that supported interpretations of results in 
qualitative studies, and absence of adjusting for con-
founding in uncontrolled studies. In studies with both a 
quantitative and qualitative component, there often was 
poor integration of the two components.
Quantitative outcomes
Quantitative results are summarized in Table 3. The most 
frequently evaluated outcomes were acute healthcare use, 
health-related quality of life and psychological outcomes. 
Four out of seven controlled studies reported a primary 
outcome: mastery of breathlessness,29 distress due to 
breathlessness,30 health-related quality of life31 and pain.32 
Janssens et al.57 had initially planned to measure acute 
healthcare use as primary outcome. However, they did not 
reach sufficient power to do so due to severe recruitment 
issues. One study found a statistically significant positive 
effect on its primary outcome; Higginson et al. reported a 
difference in mastery of breathlessness between interven-
tion and control group of 0.58 (0.01 to 1.15).
Outcomes at patient level
Quality of life—Health-related quality of life was assessed 
in ten studies,28,29,31,32,35,37,40,55–57 using seven different 
measurement instruments. Duenk et al.31 set health-
related quality of life as their primary outcome. Their 
study and that of Aiken et al.28 found significant differ-
ences between the intervention and control group on 
specific subscales but not on the total scale. The uncon-
trolled study of Van Dam et al.40 reported an improve-
ment on health-related quality of life; all other studies 
found no differences.28,29,31,32,35,37
Breathlessness—In two RCTs evaluating holistic 
breathlessness services,29,30 intervention patients 
showed higher levels of mastery of breathlessness, but 
only one study found a statistically significant differ-
ence.29 No difference was found on distress due to 
breathlessness in one RCT.30 In the study of Rabow 
et al.,32 intervention patients reported a lower degree of 





























































































































































































































































































































































































































































































496 Palliative Medicine 35(3)
breathlessness interference with daily activities and lim-
itations in daily life compared to control patients. Two 
other controlled studies did not find an effect on breath-
lessness intensity.29,37
Anxiety and depression—Rabow et al.32 reported 
reduced anxiety in intervention patients, but no change in 
depression. Eight other studies found no significant 
differences.29–31,35,37,55–57
Other health-related outcomes – Aiken et al. found 
lower symptom distress in intervention patients at three 
months, but not at six months.28 Further, positive effects 
were reported for the resumption of activities,28 sleep 
quality,32 functional capacity40 and nutritional status.40
Spiritual Well-being / Hope—In the study of Rabow 
et al., intervention patients reported higher overall spirit-
ual well-being than control patients.32 One study evaluat-
ing hope found no difference after the intervention.35
Self-management—The study of Aiken et al.28 revealed 
an improvement in illness self-management and awareness 
of resources, at specific time points. Rocker et al.35,41 found 
a positive result on the quality of preparation for self-care 
and need for information after program participation.41
Health care use—Mixed results were found regarding 
unplanned health care use. Controlled studies showed no 
effect on the number of emergency department visits or 
hospitalizations.28,31,32,55,57 Uncontrolled studies revealed 
reduction in the number of emergency department visits 
and hospitalizations.34–36,38,39 One pilot RCT reported more 
hospitalizations in the intervention group than the usual 
care group.55 A comparison of deceased intervention 
patients with other decedents showed a shorter median 
length of stay at the Intensive Care Unit.35
Advance care planning—Five studies found that, for 
intervention patients, a personal directive and advance 
care planning choices were more often documented,28,31,35,57 
and funeral arrangements were more likely to be 
completed.32
Site of death—One controlled study examining site of 
death found no differences between intervention and 
control group.32
Satisfaction with care—Two controlled studies found 
no difference between intervention and control group 
regarding satisfaction with care32,55; the uncontrolled 
study of Edes et al.34 reported an improvement.
Table 3. Summary of quantitative outcomes and results at the level of the patient, informal caregiver and healthcare professional, 
and costs.
Study design
  RCT Pilot RCT CCT BA Pilot BA
Patient
 Quality of life ⚫28 ⚪29 ⚪57⚪55 ⚪31 ⚪32 ⚫40⚪35 ⚪37 ⚪56
 Breathlessness intensity ⚪29 ⚫32 ⚪37
 Breathlessness affect ⚫29 ⚪30  
 Anxiety/Depression ⚪29 ⚪30 ⚪57⚪55 ⚫32⚪31 ⚪35 ⚪37⚪56
 Other health-related outcomes ⚫28 ⚪29 ⚪57⚪55 ⚫32 ⚫40 ⚪56
 Spiritual Wellbeing/Hope ⚫32 ⚪35  
 Self-management ⚫28 ⚫35 ⚫41  
 ED visits ⚪28 ⚪57 ⚪32 ⚫35 ⚫38 ⚫39  
 Hospital admissions ⚪57 ⦸55 ⚪31 ⚪32 ⚫34 ⚫35 ⚫36 ⚫39⚪38  
 Advance care planning ⚫28 ⚫57 ⚫31 ⚫32 ⚫35  
 Site of death ⚪32  
 Satisfaction with care ⚪55 ⚪32 ⚫34  
Informal caregiver
 Caregiver distress due to patient breathlessness ⚪30  
 Anxiety/Depression ⚪30  
Healthcare professional
 Team skills acquisition ⚫41  
Costs ⚪30 ⚪32 ⚫34 ⚫35 ⚫39  
The direction of effects and references are shown.
⚫= Positive effect—if, after statistical analysis, a significant effect was reported favouring the intervention group (RCT and non-randomized con-
trolled studies), or positive effect between baseline and after intervention (before-and-after studies).
⚪= No statistically significant effect—if, after statistical analysis, no significant effect was reported.
⚫= Mixed effects—if in that specific outcome category, more than one outcome was reported with both positive and no effects.
⦸= Negative effect—if, after statistical analysis, a significant effect was reported favouring the control group (RCT and non-randomized controlled 
studies), or a negative effect between baseline and after intervention (before-and-after studies).
BA: before and after study; CCT: non-randomized clinical controlled trial; ED: emergency department; RCT: randomized controlled trial.
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Outcomes at informal caregiver level
Only one study examined outcomes at informal caregiver 
level and found no differences in caregiver distress due to 
patient breathlessness, nor on anxiety and depression 
between the intervention and control group.30
Outcomes at healthcare professionals’ level
Outcomes at professional level were only assessed in one 
uncontrolled study. A positive effect on several skills 
regarding quality improvement and implementation was 
reported.48
Costs
Two controlled studies found no difference in healthcare 
costs of intervention patients,30,32 of which one also evalu-
ated cost-effectiveness and found high costs gained per 
quality-adjusted life-year.30 Three uncontrolled studies 
reported lower healthcare costs per patient in the period 
after the start of the intervention.34,35,39
Qualitative outcomes
Qualitative outcomes were derived from interviews in 
fourteen qualitative (sub)studies.30,35,37,41–48,52,54,55 In most 
studies, patients reported improved self-confidence to 
manage symptoms30,35,37,41,43,44,46 and positive psychologi-
cal effects.30,35,37,43,45,52 Besides, in some cases, hospitali-
zation was prevented due to earlier diagnosis and 
treatment.44–46 Regarding informal caregivers, increased 
confidence was reported because they knew how they 
could help their relatives with breathlessness.30,42 
Regarding healthcare professionals, nurses providing pal-
liative care got more insight in and understanding of the 
suffering of patients with COPD and complexities around 
COPD-care.47,48
Implementation outcomes
In the included studies, acceptability and feasibility were 
the most frequently assessed implementation outcomes. 
Supplementary Table 3 provides the operationalization of 
implementation outcomes. Acceptability was mostly 
assessed by interviewing patients,42,44,45,46,52,54,55 informal 
caregivers and referring healthcare professionals,42,44,52 
but also by using a questionnaire among participants43 or 
by collecting patient stories anecdotally.58 All studies 
reported that patients, informal caregivers and healthcare 
professionals valued the palliative care intervention. 
Components of the interventions that were highly valued 
included being listened to and direct access to a profes-
sional for support,30,35,42,44,46,50,55 continuity of 
Table 4. Barriers and facilitators for implementation (determinants) of referrers, providers and patients that were present in  
⩾3 studies.
User type Determinant Category Direction (references) Example (reference)
Referrer
 Relevance for patient Innovation Facilitator33,42,52 The innovation was perceived as helpful for 
patients, which motivated professionals to refer 
patients.52
 Awareness of content of innovation Adopting 
person
Barrier44,51,58 Referrers were not aware that the service 
existed, which hampered referral of patients to 
the innovation.44
 Disease-specific characteristics Adopting 
person
Barrier33,41,44 Due to the unpredictable disease trajectory 
of COPD, referrers found it challenging to 
determine whether a patient was at the end 
of life, and thus eligible for referral to the 
innovation.44
Provider
 Time available Organization Barrier33,41,44,48,51,55 Staff were unable to dedicate adequate time to 
the improvement efforts.33
 Staff capacity Organization Facilitator58 Consistent staffing by knowledgeable people 
aware of the program goals contributed to a 
smooth implementation of the innovation.58
Barrier33,53
 Compatibility Innovation Facilitator48 The timing of the assessment meant that actions 
overlapped with existing discharge planning.52Barrier44,52
 Financial resources Organization Barrier33,48,53 Lack of continuous resourcing was a barrier to 
implementation.48
Patient
 Accessibility Innovation Barrier33,37,41,52,53 Patients experienced difficulty travelling to 
ambulatory services.53
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the relationship44,46 and education about breathlessness 
management.30,35,42,43,50,55 Specifically regarding breath-
lessness, non-pharmacological interventions such as a 
hand-held fan and breathing techniques were reported to 
be most helpful.30,42,43,54,55 Four studies reported on inter-
vention feasibility using predefined feasibility criteria (e.g. 
participation rates and completion of the program).37,51,52,55 
The feasibility level varied and was mostly related to spe-
cific intervention context characteristics. For instance, 
Buckingham et al.52 encountered fewer actions during 
assessments than expected due to overlap of their service 
with existing discharge services. Two studies reported on 
the completion of program components (fidelity)37,51 and 
one on usefulness (appropriateness) as one of the feasibil-
ity criteria.37 One study evaluating nationwide dissemina-
tion of their approach reported on adoption and 
sustainability41,48; Fifteen of nineteen teams to which the 
intervention was disseminated incorporated all core inter-
ventions of the program and reported sustained 
improvements.
Barriers and facilitators for implementation. In ten 
articles barriers and facilitators for implementation 
(determinants) of nine different palliative care inter-
ventions were reported,33,37,41,42,44,48,51–53,55,58 mostly 
derived from interviews with referring healthcare pro-
fessionals and intervention participants. Determinants 
for referrers, providers and patients that were present 
in three or more studies are shown in Table 4. All 
determinants are shown in Supplementary Table 6.
Discussion
Main findings
This study reviewed the characteristics of multi-compo-
nent palliative care interventions for patients with COPD 
and the available evidence on their effectiveness and 
implementation, to provide guidance on future pallia-
tive care provision and to identify knowledge gaps in 
the literature. We found that a range of longitudinal and 
short-term interventions in different care settings has 
been developed to enhance palliative care provision to 
patients with COPD. Although the acceptability of the 
interventions was high among patients, informal car-
egivers and healthcare professionals, we found only lim-
ited evidence on their effectiveness. Quantitative and 
qualitative data suggest positive effects related to per-
ceived symptom control, self-management and self-
confidence. Most frequently named barriers to 
implementation were uncertainty about the timing of 
referral due to the unpredictable disease trajectory 
(referrers), time availability (providers) and accessibility 
(patients).
Interpretation of findings
The current evidence for multi-component palliative care 
interventions for patients with COPD is scarce and inconclu-
sive; only four interventions (20%) were evaluated in an 
adequately powered controlled trial; eight (40%) were eval-
uated in a pilot or feasibility study only. The assessed out-
come measures were heterogenous, and only a few 
statically significant effects were found.
Six out of seven studies found no positive effect on 
quality of life. This can be due to several reasons. First, 
just one study had quality of life set as primary outcome31 
and therefore most studies were not powered for this 
outcome. Second, it is very likely that interventions affect 
only certain dimensions of quality of life. As quality of life 
is often reported as one construct in which physical 
aspects are prominently present, effects on other dimen-
sions are likely to be missed or underestimated. A positive 
effect on health status was only seen in an inpatient pul-
monary rehabilitation intervention,40 which may be due 
to the fact that pulmonary rehabilitation is an intensive 
intervention and addresses many aspects that are 
included in health-related quality of life questionnaires. 
Third, in this patient group with end-stage disease, an 
improvement in quality of life is possibly hard to achieve 
because of the progressive nature of the disease. However, 
in patients with heart failure and cancer, significant effects 
on quality of life have been found,4,59 suggesting that 
there are perhaps other reasons specifically related to 
COPD or the conducted research.
While no consistent effects were found on health out-
comes, advance care planning activities were increased in all 
studies measuring it.28,31,32,35,57 Also, positive effects were 
reported on quantitative outcomes related to perceived con-
trol of breathlessness29 and self-management.28,35 This cor-
responds with the consistent finding from qualitative studies 
that after the intervention, patients experienced increased 
perceived control to manage their symptoms and improved 
self-confidence30,35,37,41,43,44 due to increased knowledge 
about their symptoms and the reassurance that support was 
available if necessary. In line with our findings, a recent meta-
analysis on holistic breathlessness interventions found posi-
tive effects in the affective domain of breathlessness, but not 
in level of breathlessness nor quality of life.14
Qualitative evidence suggests that longitudinal pallia-
tive care interventions prevent emergency department 
and hospital admissions in some cases due to earlier diag-
nosis and treatment.44–46 Quantitative outcomes, how-
ever, reveal mixed results. Controlled studies showed no 
differences between intervention and control group, 
whereas uncontrolled studies showed a reduction in 
emergency department and hospital admissions. This dif-
ference was also present in healthcare costs, as hospitali-
zations are responsible for the biggest part of healthcare 
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expenditures60: controlled studies reported no statisti-
cally significant differences between intervention and 
usual care patients, and uncontrolled trials showed lower 
healthcare expenses during the intervention than before. 
Either way, in line with previous reviews, our results sug-
gest that adding palliative care to usual care does not 
increase healthcare costs.4,59
Palliative care interventions targeting 
patients with COPD
Two main intervention types could be identified: short-
term palliative care assessments and longitudinal palliative 
care interventions with care coordination. Both types were 
regarded as acceptable and helpful to patients with COPD, 
and were appreciated by referring healthcare professionals 
since they meet the unaddressed needs of this patient 
group. Although the high heterogeneity of interventions 
and outcome measures prevents quantifying which com-
ponents are most beneficial, qualitative data revealed 
some characteristics that were consistently valued and per-
ceived as helpful by patients. This implies that patient and 
family education on breathlessness management, direct 
access to a professional for support and an ongoing rela-
tionship are essential components to include in future 
interventions. As these components are rather COPD-
specific than palliative care characteristics, it seems that, 
with sufficient training to healthcare professionals and dif-
ferent care organization, these components could be inte-
grated into regular COPD-care. This would meet the current 
recommendations of guidelines that integrated palliative 
care should be provided by generalist or respiratory care 
professionals, and palliative care specialists become 
involved only when care needs become complex.11,12
Implementing palliative care interventions
We identified several factors related to the implementation 
of palliative care interventions for patients with COPD. First, 
identifying eligible patients appeared challenging, as is also 
reflected by the variability in the inclusion criteria and strat-
egies used across studies. The emergency department 
appeared not to be a feasible recruitment setting for a 
home-based program,51 but barriers were also encoun-
tered in the ambulatory setting53 and during computerized 
screening.33 Using a natural transition point to identify 
patients with palliative care needs proactively, such as hos-
pitalization for an acute exacerbation,31,35,40,52 has been rec-
ommended in previous research61 and could possibly 
facilitate identification of patients. Further, palliative care 
can best be integrated within existing services to prevent 
duplication of assessments52 and to guarantee continuity of 
care. To facilitate healthcare professionals to provide pallia-
tive care, a model that can be adapted to regional needs 
and providing access to tools showed to be practical.41 For 
this vulnerable patient group with high disease burden and 
low socio-economic status, care needs to be easily accessi-
ble, as well in terms of physical distance as financially. This 
might be resolved by performing assessments during home 
visits and monitoring patient’s needs by phone. Lastly, gen-
eral organizational conditions such as sufficient time, finan-
cial resources and personnel are required for successful 
implementation.
Study quality and characteristics
The heterogeneity in methodology and used measurement 
instruments made quantitative pooling of results impossi-
ble. Among included studies, study quality was dependent 
on study design used: most controlled studies were better 
conducted than studies with a before-and-after design. As 
most studies did not report a primary outcome and power 
calculation, the studies may have been underpowered, 
causing the effects to be underestimated. On the contrary, 
four studies evaluated many outcomes without controlling 
for multiple testing,28,32,35,41 leading to an increased risk of 
unjustified positive results. Moreover, a clear difference 
was found in the direction of effects between controlled 
and uncontrolled studies, specifically with regard to acute 
healthcare use and costs. In uncontrolled studies, a positive 
effect can falsely be attributed to the intervention, leading 
to an overestimation of effect, whilst in fact, it is the reflec-
tion of the normal disease course or other influences.
Furthermore, the included studies provided little infor-
mation on the actual delivery of the intervention. As a 
consequence, it remains unclear whether or not the 
inconsistency of effects found is due to implementation 
errors.
Recommendations for future research
For future evaluations, outcomes should be chosen related 
to the goal of the intervention. Quality of life, although the 
ultimate goal of palliative care, might be a rather distal 
outcome measure and difficult to modify in this patient 
group. Qualitative research can identify which outcomes 
are most important to patients with end-stage COPD and 
can increase our understanding of the underlying working 
mechanisms and what works for whom and under what 
circumstances. Eventually, consensus on the outcome sets 
to be used is needed in order to compare different inter-
ventions and to be able to conduct meta-analyses. Our 
review revealed a striking difference between the results 
of quantitative and qualitative studies included. This may 
be due to the different focus of these two methods. 
Qualitative research mainly aims to examine the experi-
ences of individuals, and not health effects. In general, 
additional care or attention from a professional will result 
in a more positive patient evaluation. That being said, the 
added value of palliative care interventions in COPD may 
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just be to improve those subjective experiences of indi-
viduals in their final stage of the disease. Therefore, we 
argue that the discrepancy found between the quantita-
tive and qualitative results advocates for a reconsideration 
of research outcome choices. Hence, we should consider 
what can most significantly impact the patients’ well-being 
and experience, and not solely focus on health effect 
parameters. Additionally, we were surprised to find so few 
outcomes at informal caregiver and professional level. We 
recommend to include outcomes such as informal car-
egiver burden and professional’s self-efficacy, to acquire 
knowledge on how informal caregivers can be supported 
and how professionals can be equipped with the neces-
sary skills. Next, we recommend that future research 
includes comprehensive process evaluations to unravel 
requirements for successful implementation and to 
explore implementation strategies that enhance adoption 
of new care practices. Various validated tools can be used 
for this purpose, such as the TIDieR checklist for reporting 
of intervention characteristics and monitoring interven-
tion fidelity.62 Also, the Measurement Instrument for 
Determinants of Innovations framework and Context and 
Implementation of Complex Interventions framework 
have been previously used in the palliative care research 
field and can be used in future studies to measure imple-
mentation determinants and contextual factors.63,64
Strengths and limitations
To our knowledge, this is the first study reviewing all evi-
dence on the effectiveness and implementation of pallia-
tive care interventions in COPD. Since we did not exclude 
studies based on design or quality, we were able to use all 
available information in literature in order to give a broad 
overview. We used a comprehensive and broad search 
strategy across multiple databases. Study selection, qual-
ity assessment and data extraction were conducted by 
two authors independently. Implementation outcomes 
and barriers and facilitators to implementation were cat-
egorized using well-established operationalizations.
This systematic review also has some limitations. 
Although we used a broad search strategy across data-
bases, we included articles only if the authors referred to 
the intervention as “palliative.” This allowed us to use a 
clear and objective criterion, as there are no fixed criteria 
which characteristics an intervention must have in order to 
be labelled as palliative care, nor which patients with COPD 
should be labelled as “palliative patients.” As a conse-
quence, we disregarded interventions targeting patients 
with severe COPD, but were not referred to as palliative. 
This may have resulted in the exclusion of relevant inter-
ventions with similar intervention characteristics. Due to 
poor reporting and inconsistent terminology used across 
studies, categorization of characteristics, implementation 
outcomes and barriers and facilitators was sometimes dif-
ficult. Since all study designs were included, there was high 
methodological variation between studies and variation in 
risk of bias. Also, there was heterogeneity in used measure-
ment instruments. For these reasons, the results of the syn-
thesized evidence have to be interpreted with caution.
Conclusion
Although the relevance of palliative care interventions for 
patients with COPD and their informal caregivers has been 
widely acknowledged, this study found that little high-qual-
ity evidence is available on the effectiveness and imple-
mentation of palliative care interventions in COPD-care. 
There is a need for well-conducted controlled effectiveness 
studies of sufficient power to reach definite conclusions, 
and that also explore which characteristics of palliative care 
complex interventions in COPD are especially effective and 
for whom. Finally, with clearer results, its implementation 
should be facilitated and documented with adequate pro-
cess evaluations using standardized methodologies.
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